Pharmacokinetics, Safety, and Efficacy of ASTX727 in Combination With Venetoclax in Acute Myeloid Leukemia (AML)
Clinical trial NCT04657081 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04657081
- Sponsor
- Taiho Oncology, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-02-09
- Primary completion
- 2024-09-30
- Enrollment
- 101
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.